Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! Nov 06, 2024
Read More Apparatus Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Medical Neratinib Included In NCCN Guidelines For Specific HER2-Negative Breast Cancers Nov 03, 2024
Read More Apparatus The world's smallest surgical robot "Versius", with a quotation of 2 million pounds Nov 19, 2024
